Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Psychodynamic Therapy01:29

Psychodynamic Therapy

Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch01:15

Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch

The history of therapeutic communication can be traced back to Florence Nightingale, who emphasized the importance of developing trusting relationships with patients. She taught that the presence of nurses with patients results in therapeutic healing.
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D skeletal muscle system for disease modelling and secretome profiling of Duchenne muscular dystrophy.

Skeletal muscle·2026
Same author

Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.

Journal for immunotherapy of cancer·2026
Same author

Circulating Extracellular Vesicles in Alcoholic Liver Disease Affect Skeletal Muscle Homeostasis and Differentiation.

Journal of cachexia, sarcopenia and muscle·2025
Same author

Generation of Bidimensional and Three-Dimensional Muscle Culture Systems.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Impaired myoblast differentiation and muscle IGF-1 receptor signaling pathway activation after N-glycosylation inhibition.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2024
Same author

MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients.

Neuromolecular medicine·2024

Related Experiment Video

Updated: May 16, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Understanding ALS: new therapeutic approaches.

Antonio Musarò1

  • 1Institute Pasteur Cenci Bolognetti, Istituto Italiano di Tecnologia, Department of Anatomy, Histology, Forensic Medicine and Orthopedics - Unit of Histology and Medical Embryology, Istituto Interuniversitario di Miologia, Sapienza University of Rome, Italy. antonio.musaro@uniroma1.it

The FEBS Journal
|December 11, 2012
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective therapy. Understanding its complex mechanisms is crucial for developing new treatments for this multi-factorial condition.

Keywords:
ALS-associated genesamyotrophic lateral sclerosiscomplexity of ALS pathogenesisgrowth factorsmutant SOD1 toxicityneuromuscular diseaseoxidative stressskeletal musclestem cellstherapeutic approaches

More Related Videos

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

Related Experiment Videos

Last Updated: May 16, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motor neuron degeneration, muscle atrophy, and paralysis.
  • Despite advancements in understanding pathological mechanisms, ALS remains untreatable and invariably fatal.
  • The disease's heterogeneity suggests a multi-factorial and multi-systemic nature, necessitating a comprehensive approach to therapy.

Purpose of the Study:

  • To review the pathogenic mechanisms underlying ALS.
  • To discuss the strengths and limitations of emerging therapeutic strategies for ALS.
  • To highlight the need for a deeper understanding of inter-cellular pathological relationships in ALS.

Main Methods:

  • Literature review of current research on ALS pathogenesis.
  • Analysis of existing and novel therapeutic approaches for ALS.
  • Synthesis of information on the multi-factorial nature of ALS.

Main Results:

  • Multiple pathological mechanisms contribute to ALS, but a complete understanding remains elusive.
  • Current therapeutic protocols have largely failed, underscoring the disease's complexity.
  • New therapeutic strategies show promise but face significant limitations.

Conclusions:

  • ALS is a complex, multi-factorial disease requiring a multi-systemic therapeutic strategy.
  • Further research into the intricate pathogenic mechanisms and cellular interactions is essential for effective ALS treatment.
  • Developing efficacious therapies for ALS necessitates a holistic understanding of the disease's pathology.